InterWest Partners IX, LP's Net Worth
-$25.7 Million
Who is InterWest Partners IX, LP?
InterWest Partners IX, LP does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Trius Therapeutics Inc, GLAUKOS Corp, Carbylan Therapeutics, Inc., Marketo, Inc., Restoration Robotics Inc, EnteroMedics Inc, and Transcept Pharmaceuticals Inc.
SEC CIK
InterWest Partners IX, LP's CIK is 0001398928
Past Insider Trading and Trends
2010 was InterWest Partners IX, LP's most active year for acquiring shares with 6 total transactions. InterWest Partners IX, LP's most active month to acquire stocks was the month of July. 2010 was InterWest Partners IX, LP's most active year for disposing of shares, totalling 4 transactions. InterWest Partners IX, LP's most active month to dispose stocks was the month of July. 2010 saw InterWest Partners IX, LP paying a total of $18,795,114.96 for 7,097,286 shares, this is the most they've acquired in one year. In 2010 InterWest Partners IX, LP cashed out on 27,121,214 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
EnteroMedics Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +724.94% | 1.36M |
—
|
—
| 1.55M |
Nov 20
| |||
Form 4
|
∞
| 187.5K |
$8.00 | $1,500,000.00 | 187.5K |
Nov 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Trius Therapeutics Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.55M |
$4.77 |
—
| 3.55M |
Aug 6
| |||
Form 4
|
∞
| 3.55M |
$4.77 |
—
| 3.55M |
Aug 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
GLAUKOS Corp (GKOS) Snapshot price: $129.28
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.6M |
—
|
—
| 2.6M |
Jun 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Carbylan Therapeutics, Inc. (KALV) Snapshot price: $12.34
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 4.62M |
$5.00 |
—
| 4.62M |
Apr 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Marketo, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -71.64% | -124.48K |
$24.31 | -$3,006,776.01 | 49.27K |
May 29 - May 30
| |||
Form 4
| -17.35% | -848.00K |
—
|
—
| 4.04M |
May 28
| |||
Form 4
| -39.07% | -10.00K |
$24.01 | -$240,090.00 | 15.6K |
May 20 - May 21
| |||
Form 4
| -36.95% | -15.00K |
$22.96 | -$344,427.00 | 25.6K |
May 16
| |||
Form 4
| -100.00% | -34.46K |
$24.27 | -$836,427.15 |
0
|
May 13 - May 14
| |||
Form 4
| -14.63% | -848.00K |
—
|
—
| 4.95M |
May 12
| |||
Form 4
| -61.95% | -24.42K |
$41.96 | -$1,024,605.20 | 15K |
Feb 27 - Feb 28
| |||
Form 4
| -61.55% | -33.05K |
$40.33 | -$1,334,791.50 | 20.65K |
Feb 26
| |||
Form 4
| -18.79% | -1.35M |
—
|
—
| 5.85M |
Feb 25
| |||
Form 4
| -100.00% | -4.35K |
$40.70 | -$177,045.00 |
0
|
Feb 13
| |||
Form 4
| -5.89% | -451.49K |
—
|
—
| 7.21M |
Feb 12
| |||
Form 4
| -21.37% | -2.08M |
$33.99 | -$70,818,664.12 | 7.66M |
Sep 18
| |||
Form 4
|
∞
| 9.75M |
—
|
—
| 9.75M |
May 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||